Login / Signup

Glycosylation is crucial for a proper catalytic site organization in human glucocerebrosidase.

Laercio P FachinMarina SiebertHugo VerliMaria Luiza Saraiva-Pereira
Published in: Glycoconjugate journal (2016)
Gaucher disease, an autosomal recessive disorder, is caused by a deficiency of glucocerebrosidase (GCase) enzyme, a peripheral membrane-associated glycoprotein that hydrolyses glucosylceramide in lysosomes. Glycosylation is essential for the development of a catalytically active enzyme, specifically in the first site, located at Asn19. However, both the molecular basis of the relevance of N-glycosylation over GCase activity and the effects of glycosylation over its structure and dynamics are still not fully understood. Thus, the present work evaluated GCase enzyme in increasing glycosylation content using triplicate unbiased molecular dynamics simulations. Accordingly, the N-linked glycan chains caused local conformational stabilization effects over the protein, as well as in regions flanking the enzyme catalytic dyad. In the case of the Asn19-linked glycan, it also occurred around region 438-444, where one of the most prevalent GCase mutations is found. Markedly, an increasing catalytic dyad organization was related to increasing glycosylation contents, offering the first atomic-level explanation for the experimental observation that GCase activity is controlled by glycosylation, especially at Asn19.
Keyphrases
  • molecular dynamics simulations
  • endothelial cells
  • molecular docking
  • molecular dynamics
  • replacement therapy
  • protein protein
  • binding protein
  • chemotherapy induced
  • pluripotent stem cells